April 1, 2026
Nexsen (ASX:NXN) secures HK$6M grant to advance Asia Pacific go-to-market strategy
Nexsen secures HK$6M in non dilutive funding to accelerate clinical validation and manufacturing of its StrepSure® diagnostic in Asia Pacific.